Cis-acting super-enhancer lncRNAs as biomarkers to early-stage breast cancer.

Ali S RopriRebecca S DeVauxJonah EngSridar V ChitturJason I Herschkowitz

Published in: Breast cancer research : BCR (2021)

Collectively, these analyses identify differentially expressed SE-lncRNAs and acquired/lost super-enhancers in progression of breast cancer important for promoting DCIS lesions to IDC.

Keyphrases

early stage
network analysis
transcription factor
genome wide identification
genome wide analysis
binding protein
squamous cell carcinoma
radiation therapy
young adults
sentinel lymph node
breast cancer risk
neoadjuvant chemotherapy
locally advanced